v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock
Common Stock Class A
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     181,945,771      
Beginning balance at Dec. 31, 2023 $ 9,732,552   $ 182 $ 14,797,723 $ 619 $ (5,065,972)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (87,207)         (87,207)
Exercises of vested stock options (in shares)     71,433      
Exercises of vested stock options 1,099     1,099    
Vesting of restricted stock units (in shares)     3,080,464      
Vesting of restricted stock units 0   $ 2 (2)    
Value of equity awards withheld for tax liability (in shares)     (27,537)      
Value of equity awards withheld for tax liability (1,963)     (1,963)    
Shares issued under ESPP (in shares)     394,479      
Shares issued under ESPP 20,601     20,601    
Shares of Class A common stock issued and donated to charity (in shares)     44,204      
Shares of Class A common stock issued and donated to charity 2,610     2,610    
Shares returned from escrow (in shares)     (696)      
Shares returned from escrow (192)     (192)    
Unrealized gain (loss) on marketable securities (7,014)       (7,014)  
Repurchases of shares of Class A common stock including related costs (in shares)     (21,358,029)      
Repurchases of shares of Class A common stock including related costs (1,293,647)   $ (20)     (1,293,627)
Net change in market value of effective foreign currency forward exchange contracts (5,328)       (5,328)  
Share of other comprehensive (loss) income from equity method investment 1,052       1,052  
Stock-based compensation 314,462     314,462    
Stock-based compensation - restructuring 2,448     2,448    
Ending balance (in shares) at Jun. 30, 2024     164,150,089      
Ending balance at Jun. 30, 2024 8,679,473   $ 164 15,136,786 (10,671) (6,446,806)
Beginning balance (in shares) at Mar. 31, 2024     177,471,887      
Beginning balance at Mar. 31, 2024 9,447,730   $ 177 14,960,837 (4,941) (5,508,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (31,858)         (31,858)
Exercises of vested stock options (in shares)     27,598      
Exercises of vested stock options 678     678    
Vesting of restricted stock units (in shares)     1,464,534      
Vesting of restricted stock units 0   $ 1 (1)    
Value of equity awards withheld for tax liability (in shares)     (780)      
Value of equity awards withheld for tax liability (45)     (45)    
Shares issued under ESPP (in shares)     394,479      
Shares issued under ESPP 20,601     20,601    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 1,315     1,315    
Unrealized gain (loss) on marketable securities (1,821)       (1,821)  
Repurchases of shares of Class A common stock including related costs (in shares)     (15,229,731)      
Repurchases of shares of Class A common stock including related costs (906,619)   $ (14)     (906,605)
Net change in market value of effective foreign currency forward exchange contracts (823)       (823)  
Share of other comprehensive (loss) income from equity method investment (3,086)       (3,086)  
Stock-based compensation 153,401     153,401    
Ending balance (in shares) at Jun. 30, 2024     164,150,089      
Ending balance at Jun. 30, 2024 8,679,473   $ 164 15,136,786 (10,671) (6,446,806)
Beginning balance (in shares) at Dec. 31, 2024   152,610,697 152,610,697      
Beginning balance at Dec. 31, 2024 7,952,966   $ 153 15,476,124 (1,301) (7,522,010)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 42,440         42,440
Exercises of vested stock options (in shares)     357,224      
Exercises of vested stock options 5,150     5,150    
Vesting of restricted stock units (in shares)     3,343,830      
Vesting of restricted stock units 0   $ 4 (4)    
Value of equity awards withheld for tax liability (in shares)     (1,084)      
Value of equity awards withheld for tax liability (138)     (138)    
Shares issued under ESPP (in shares)     253,298      
Shares issued under ESPP 20,757     20,757    
Shares of Class A common stock issued and donated to charity (in shares)     44,204      
Shares of Class A common stock issued and donated to charity 5,013     5,013    
Unrealized gain (loss) on marketable securities 3,942       3,942  
Repurchases of shares of Class A common stock including related costs (in shares)     (3,032,011)      
Repurchases of shares of Class A common stock including related costs (306,522)   $ (3)     (306,519)
Net change in market value of effective foreign currency forward exchange contracts 24,207       24,207  
Share of other comprehensive (loss) income from equity method investment (2,132)       (2,132)  
Stock-based compensation 298,239     298,239    
Ending balance (in shares) at Jun. 30, 2025   153,576,158 153,576,158      
Ending balance at Jun. 30, 2025 8,043,922   $ 154 15,805,141 24,716 (7,786,089)
Beginning balance (in shares) at Mar. 31, 2025     153,254,342      
Beginning balance at Mar. 31, 2025 8,004,291   $ 153 15,625,545 10,358 (7,631,765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 22,423         22,423
Exercises of vested stock options (in shares)     225,709      
Exercises of vested stock options 2,384     2,384    
Vesting of restricted stock units (in shares)     1,631,186      
Vesting of restricted stock units 0   $ 2 (2)    
Value of equity awards withheld for tax liability (in shares)     (661)      
Value of equity awards withheld for tax liability (85)     (85)    
Shares issued under ESPP (in shares)     253,298      
Shares issued under ESPP 20,757     20,757    
Shares of Class A common stock issued and donated to charity (in shares)     22,102      
Shares of Class A common stock issued and donated to charity 2,237     2,237    
Unrealized gain (loss) on marketable securities (1,116)       (1,116)  
Repurchases of shares of Class A common stock including related costs (in shares)     (1,809,818)      
Repurchases of shares of Class A common stock including related costs (176,748)   $ (1)     (176,747)
Net change in market value of effective foreign currency forward exchange contracts 15,821       15,821  
Share of other comprehensive (loss) income from equity method investment (347)       (347)  
Stock-based compensation 154,305     154,305    
Ending balance (in shares) at Jun. 30, 2025   153,576,158 153,576,158      
Ending balance at Jun. 30, 2025 $ 8,043,922   $ 154 $ 15,805,141 $ 24,716 $ (7,786,089)